Shimadzu Opens "Laboratory World" in Germany
Shimadzu officially opened a new laboratory building called ?Laboratory World? at the company?s headquarters in Duisberg, Germany on the 15th of April,. The building was officially opened in a traditional Japanese ceremony by the President and CEO of Shimadzu, Akira Nakamoto; the Japanese Consul, Kiyoshi Koinuma; and Duisberg?s Lord Mayor, Soren Link.
Shimadzu officially opened a new laboratory building called “Laboratory World” at the company’s headquarters in Duisberg, Germany on the 15th of April. The building was officially opened in a traditional Japanese ceremony by the President and CEO of Shimadzu, Akira Nakamoto; the Japanese Consul, Kiyoshi Koinuma; and Duisberg’s Lord Mayor, Soren Link.
Shimadzu invested €3.2 million into the laboratory that covers over 1,500m 2. The laboratory features training and testing facilities for scientists throughout Europe. The entire product range offered by Shimadzu will be available for demonstration, with an area specially dedicated to mass spectrometry technology and instrumentation.
The laboratory will provide a range of opportunities for Shimadzu and customers, according to Jürgen Kwass, Managing Director of Shimadzu Europa. Kwass added, ”In addition, we offer continuing education and training to customers as well as staff members. Another goal is to create an inspiring atmosphere for our team in which they can develop new methods and technologies for future-oriented products."
For more information please visit:
www.shimadzu.eu
href="http://images2.advanstar.com/PixelMags/lctc/digitaledition/May02-2013.html ">This story originally appeared in
The Column.
Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
